Z-0294-2022 Class II Ongoing

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-0294-2022 was initiated by Medtronic Neuromodulation on Nov 4, 2021 and is designated Class II. Reason for recall: The wireless rechargers (WR; WR9200 and WR9220; included in the Recharger Kits) become unresponsive if the charging steps, indicated in the Recharger Patient User Guide, are not followed. The recall status is ongoing. Affected quantity: 6,406 devices.

Recall details

Product Type
Devices
Report Date
Dec 1, 2021
Initiation Date
Nov 4, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,406 devices

Product description

Medtronic Wireless Recharger Model WR9200 included in the RS6200 Recharger Kit used by the Activa RC (Model 37612) implantable neurostimulator.

Reason for recall

The wireless rechargers (WR; WR9200 and WR9220; included in the Recharger Kits) become unresponsive if the charging steps, indicated in the Recharger Patient User Guide, are not followed.

Distribution pattern

US Nationwide, including PR. There was government distribution but no military distribution was identified.

Code information

UDI 00763000185152

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0294-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0294-2022. Report a data issue: hello@regdatalab.com.